DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Alkermes, Inc. (NASDAQ: ALKS)

61.35 -0.45 (-0.73%)

REAL-TIME: Last trade at

Extended Hours: $61.35 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ALKS $61.35 -0.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.11
Previous Close $61.80
Daily Range $60.75 - $61.94
52-Week Range $38.49 - $75.17
Market Cap $9.1B
P/E Ratio -247.20
Dividend (Yield) $0.00 (0.0%)
Volume 592,665
Average Daily Volume 1,076,390
Current FY EPS -$0.98

Sector

Healthcare

Industry

Drug Makers

Alkermes, Inc. (ALKS) Description

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Website: http://www.alkermes.com/

News & Commentary Rss Feed

A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics

Alkermes Plc's ALKS 3831 could help patients that take atypical antidepressants avoid gaining weight.

3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog

3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog

Benzinga's Top Initiations

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and

Top Analyst Upgrades and Downgrades: Alibaba, Mobileye, NetApp, Nike, Salesforce.com, Stratasys and More

4 SMID-Cap Biotechs Barclays Just Confessed It Loves

First Week of ALKS July 17th Options Trading

Top Analyst Upgrades and Downgrades: Alkermes, Cisco, Gap, Rackspace, SouFun, Verizon and More

Alkermes' Q1 Loss Narrower than Expected, Maintains View - Analyst Blog

Alkermes (ALKS) Earnings Report: Q1 2015 Conference Call Transcript

ALKS Makes Notable Cross Below Critical Moving Average

Alkermes' (ALKS) CEO Richard Pops on Q1 2015 Results - Earnings Call Transcript

See More ALKS News...

ALKS's Top Competitors

ALKS $61.35 (-0.73%)
Current stock: ALKS
AMGN $163.59 (-0.15%)
Current stock: AMGN
GILD $111.71 (0.44%)
Current stock: GILD
BIIB $398.68 (-0.62%)
Current stock: BIIB